Proteomics International | GenomeWeb

Proteomics International

The company said it will use the funds to commercialize its proteomic PromarkerD kidney disease test and launch an analytical testing service business.

Named PromarkerD, the test is intended to predict risk of developing kidney disease in diabetics and diagnose patients with diabetic kidney disease.

The Australian company has also inked a deal to launch its proteomics-based kidney disease test in China. 

The firm seeks to raise between A$4 million and A$6 million through an offering of up to 30 million shares of its stock at A$.20 per share.

NEW YORK (GenomeWeb News) – Proteomics International recently announced an agreement with inVentiv Health Clinical aimed at the development of biosimilars.

Exact Sciences' shareholders have re-elected three members of its board of directors, including company President and CEO Kevin Conroy, as well as Katherine Napier, and David Thompson.

Proteomics firm Proteomics International said this week that it has received a A$1 million (US$ 1 million) grant from Commercialisation Australia – an initiative of the Australian government – to develop its protein biomarkers for diabetic nephropathy into a companion diagnostic.

NEW YORK (GenomeWeb News) – The Australian government has awarded Proteomics International A$1 million (US$ 1 million) to develop biomarkers for diabetic kidney disease into a companion diagnostic test.

The company presented a panel of 13 biomarkers for the disease at last month's Human Proteome Organization annual meeting and is looking for partners and funding to develop it as a commercial diagnostic.

1st Base will promote Protoemics International's proteomics services in Singapore, Malaysia, Indonesia, and Thailand.

Pages

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.